medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2020, Number 1

<< Back Next >>

Rev Mex Patol Clin Med Lab 2020; 67 (1)

Mayaro virus. The new threat?

Barba EJR

Language: Spanish
References: 22
Page: 49-58
PDF size: 329.96 Kb.


ABSTRACT

Since 2000, our country has been affected by outbreaks of some arboviruses, mainly those that cause dengue (DENV), chikunguña (CHIKV) and zika (ZIKV), which once the first cases were detected has not been possible eradication. In the same way as with the aforementioned viruses, the virus causing Mayaro fever (MAYV) is undoubtedly another potential threat to be introduced and established in Mexico, this mainly due to viral infections transmitted by arthropod vectors hematophages (which are mostly mosquitoes of various species), are difficult to control and prevent their spread, mainly because the habitat of these vectors is very wide, so it is only possible to contain their reproduction through programs of fumigation, as well as educating the affected population by adopting preventive measures that basically consist in the elimination of objects that accumulate water as well as the use of mosquito nets. On the other hand, it is difficult to know the incidence of Mayaro fever in the Mexican population, on the one hand because this infection presents a clinical picture similar to other viruses of the Togaviridae family, especially of the genus alphavoirus, which can lead to under-registration of cases mainly due to the lack of confirmation through results of infectious serology that confirms or discards the causative agent, and on the other hand there is the short duration of viremia in this infection, which may limit the usefulness of the clinical laboratory.


REFERENCES

  1. Cabello CC, Cabello CF. Zoonosis con reservorios silvestres: amenazas a la salud pública y a la economía. Rev Méd Chile. 2008; 136: 385-393.

  2. Zúñiga CI, Caro LJ. Virus Mayaro: una nueva amenaza para el continente Americano. Rev Latin Infect Pediatr. 2017; 30 (1): 12-14.

  3. Cárdenas MM, Pech SN, Arias LJ. Fiebre Mayaro: enfermedad emergente al acecho. Ciencia Humanismo Salud. 2016; 3 (3): 32-40.

  4. Barón CA, Munguía MID. Dengue, chikungunya, zika y Mayaro, amenazas para la salud en Honduras. Rev Fac Cienc Méd. 2017: 44-57.

  5. Arévalo CY, Bogotá SM, Cortés PL, Sierra VA, Moscoso J, Méndez WA. Virus Mayaro: un arbovirus que amenaza a Colombia. Revista de Medicina e Investigación UAEMéx. 2017; 5 (2): 98-108.

  6. Arredondo GJ, Méndez HA, Medina CH. Arbovirus en Latinoamérica. Acta Pediatr Mex. 2016; 37 (2): 111-131.

  7. Muñoz M, Navarro JC. Virus Mayaro: un arbovirus reemergente en Venezuela y Latinoamérica. Biomédica. 2012; 32: 286-302.

  8. Wang E, Paessler S, Aguilar PV, Carrara AS, Ni H, Greene IP, Weaver SC. Reverse transcription PCR enzyme linked immunosorbent assay for rapid detection and differentiation of alphavirus infections. J Clin Microbiol. 2006; 44 (11): 4000-4008.

  9. Tesh RB, Watts DM, Russell KL, Damodaran C, Calampa C, Cabezas C et al. Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis. 1999; 28: 67-73.

  10. Ríos GC, De Benedictis SG, Chirino CA. Conocimientos, actitudes y prácticas sobre el Virus Mayaro en estudiantes de medicina, 2017. Rev Inst Med Trop. 2018; 13 (1): 32-39.

  11. De Thoisy B, Gardon J, Salas RA, Morvan J, Kazanji M. Mayaro virus in wild mammals, French Guiana. Emerging Infectious Diseases. 2003; 9 (10): 1326-1329.

  12. Izurieta R, DeLacure D, Izurieta A, Hoare I, Reina OM. Mayaro virus: the jungle flu. Virus Adaptation and Treatment. 2018; 10: 9-17.

  13. Alves ED, Lopes da Fonseca BA. Will Mayaro virus be responsible for the next outbreak of an arthropod-borne virus in Brazil? Braz J Infect Dis. 2017; 21 (5): 540-544.

  14. Auguste AJ, Liria J, Forrester NL, Giambalvo D, Moncada M, Long KC et al. Evolutionary and ecological characterization of Mayaro virus strains isolated during an Outbreak, Venezuela, 2010. Emerg Infect Dis. 2015; 21 (10): 1742-1750.

  15. García FM, Moraes FL. Emerging alphaviruses in the Americas: chikungunya and Mayaro. Rev Soc Bras Med Trop. 2014; 47 (6): 677-683.

  16. Danillo Lucas Alves E, Benedito Antonio Lopes da F. Characterization of the immune response following in vitro Mayaro and chikungunya viruses (Alphavirus, Togaviridae) infection of mononuclear cells. Virus Research. 2018; 256: 166-173.

  17. Mattar VS, González TM. Mayaro y chikungunya; dos alfavirus con similitudes clínicas y epidemiológicas. Rev MVZ Córdoba. 2015; 20 (Supl.): 4861-4863.

  18. Long KC, Ziegler SA, Thangamani S, Hausser NL, Kochel TJ, Higgs S, Tesh RB. Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg. 2011; 85 (4): 750-757.

  19. Cabezas C, Donaires F. Enfoque sindrómico para el diagnóstico y manejo de enfermedades infecciosas febriles agudas en situaciones de emergencia. Rev Peru Med Exp Salud Pública. 2017; 34 (2): 316-322.

  20. Alerta Epidemiológica Fiebre de Mayaro. Organización Panamericana de la salud 1 de mayo de 2019.

  21. Estudio interinstitucional desarrollado por las instituciones del Ministerio de Salud del Perú, Instituto de Investigación de Enfermedades Tropicales de la Marina de los Estados Unidos, Universidad Nacional Mayor de San Marcos , Universidad Peruana Cayetano Heredia. Perfil etiológico del síndrome febril en áreas de alto riesgo de transmisión de enfermedades infecciosas de impacto en salud pública en el Perú, 2000-2001. Rev Peru Med Exp Salud Publica. 2005; 22 (3): 165-174.

  22. Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ, Ramal C et al. Mayaro Virus Infection, Amazon Basin Region, Peru, 2010-2013. Emerg Infect Dis. 2013; 19 (11): 1839-1842.




2020     |     www.medigraphic.com